Hancock Mark

Director, Co Fndr; Exec V Chair, 10% Owner, Co Fndr; Int CFO; Exec V Chair, Co-Founder & Exec. Vice Chair. · SEC CIK 2014361
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$339.2M
8 trades
Net flow
−$339.2M
Net selling
Total filings
12
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
PACS
Sell Hancock Mark · Director, Co Fndr; Exec V Chair, 10% Owner · Open-market sale · filed 4d ago ΔOwn −0.1%

Hancock Mark sold $2.13M of PACS.

−$2.13M
60,364 sh @ $35
PACS
Sell Hancock Mark · Director, Co Fndr; Exec V Chair, 10% Owner · Open-market sale · filed 4d ago

Hancock Mark sold $118.5K of PACS.

−$118.5K
3,316 sh @ $36
PACS
Sell Hancock Mark · Director, Co Fndr; Exec V Chair, 10% Owner · Open-market sale · filed 1w ago ΔOwn −0.2%

Hancock Mark sold $2.98M of PACS.

−$2.98M
83,066 sh @ $36
PACS
Sell Hancock Mark · Director, Co Fndr; Exec V Chair, 10% Owner · Open-market sale · filed 1w ago ΔOwn −0.2%

Hancock Mark sold $4.86M of PACS.

−$4.86M
134,093 sh @ $36
PACS
Sell Hancock Mark · Director, Co Fndr; Exec V Chair, 10% Owner · Open-market sale · filed 1w ago

Hancock Mark sold $709.1K of PACS.

−$709.1K
19,138 sh @ $37
Advertisement
PACS
Sell Hancock Mark · Director, Co Fndr; Exec V Chair, 10% Owner · Open-market sale · filed 1w ago

Hancock Mark sold $871 of PACS.

−$871
23 sh @ $38
PACS
Grant/award Hancock Mark · Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner · Grant/award · filed Mar 26, 2026 ΔOwn +0.2%
+$0
98,154 sh
PACS
Gift Hancock Mark · Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner · Gift · filed Mar 9, 2026 ΔOwn −0.5%
−$0
300,000 sh
PACS
Tax withholding Hancock Mark · Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner · Tax withholding · filed Jan 20, 2026
−$504.4K
12,774 sh @ $39
PACS
Grant/award Hancock Mark · Director, Co Fndr; Int CFO; Exec V Chair, 10% Owner · Grant/award · filed Dec 19, 2025 ΔOwn +0.1%
+$0
41,018 sh
PACS
Sell Hancock Mark · Director, Co-Founder & Exec. Vice Chair., 10% Owner · Open-market sale · filed Sep 10, 2024 ΔOwn −15%

Hancock Mark sold $294.65M of PACS, trimming their stake 15%.

−$294.65M
8.13M sh @ $36
PACS
Sell Hancock Mark · Director, Co-Founder & Exec. Vice Chair., 10% Owner · Open-market sale · filed Apr 15, 2024 ΔOwn −2.5%

Hancock Mark sold $33.75M of PACS, trimming their stake 2%.

−$33.75M
1.61M sh @ $21

Frequently asked questions

How is Hancock Mark's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Hancock Mark's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.